ESC Premium Access

Late Breaking Science in Prevention

Event: ESC Congress 2021 - The Digital Experience
Topic: Lipids
Session type: Late-Breaking Science
Date: 29 August 2021
Time: 10:30 - 11:15

Congress Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

NATURE-PCSK9 trial

Speaker: Professor B. Ference (Cambridge, GB)
Thumbnail

Fixed Dose Combination Therapies with or without Aspirin in Primary Prevention of Cardiovascular Disease

Speaker: Doctor P. Joseph (Hamilton, CA)
Thumbnail

Explanations for contrasting results of REDUCE-IT vs. STRENGTH

Speaker: Doctor T. Doi (Herlev, DK)
Thumbnail

3 speakers from this session

Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
25 presentations
1 follower

Doctor Philip Joseph

Population Health Research Institute, Hamilton (Canada)
1 presentation
0 follower

Doctor Takahito Doi

Herlev Hospital, Herlev (Denmark)
1 presentation
0 follower

Related content

ESC Premium Access

Pregnancy in women with cardiovascular disease

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk